Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1a,Condition 1b 3073,"Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012.",vasodilation trait,,RS:0002538,SHRSP/A3NCrl,male,148 days to 141 days,14,,CMO:0003415,GSK2181236A-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel,,percent reversal of contractile response to 0.3uM phenylephrine,,110,%,3.0,11.225,MMO:0000207,tissue force analysis utilizing a force transducer,,0.0,,,,,control condition,107312,control condition, 3073,"Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012.",vasodilation trait,,RS:0002538,SHRSP/A3NCrl,male,148 days to 141 days,8,,CMO:0003415,GSK2181236A-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel,,percent reversal of contractile response to 0.3uM phenylephrine,,110,%,7.0,19.799,MMO:0000207,tissue force analysis utilizing a force transducer,,0.0,,,,,controlled sodium chloride content drinking water (1 %) (for 56 days) and controlled fat content diet (24.5 %) (for 56 days),107313,controlled sodium chloride content drinking water (1 %) (for 56 days),controlled fat content diet (24.5 %) (for 56 days)